Antibodies

CST antibodies using the Cell DIVE multiplexed imaging solution
#Antibodies #Biomarkers #Cancer research #Collaboration #Drug discovery #Partnership

New antibody validation partnership hopes to “power scientific discovery” 

Leica Microsystems and Cell Signaling Technology (CST) have agreed a partnership to validate CST antibodies on the Cell DIVE multiplexed imaging solution.  As an open multiplexing system, Cell DIVE allows researchers to design custom antibody biomarker panels.  James O’Brien, Vice President Life Sciences at Leica Microsystems, said: “Instead of spending… Read More

#Business & Investment #News

Synthetic DNA
#AI #Antibodies #Biotechnology #Drug development #Drug discovery #Synthetic biology #Synthetic DNA #Synthetic libraries

Synthetic biology tools advancing and accelerating drug discovery efforts

Anita Ramanathan outlines four synthetic biology approaches that are improving and accelerating drug discovery.  The brainchild of multidisciplinary experts in computer science, physics, engineering, and biology, the field of synthetic biology has not only rapidly progressed in the last few decades but it’s also becoming more accessible and cost-effective. It has made its… Read More

#Exclusive Content

Biomarkers concept
#Antibodies #Biomarkers #Cell signalling #Cellular imaging #Microsystems

Data collection that empowers scientific discoveries 

Leica Microsystems and Cell Signaling Technology (CST) have announced a partnership to validate CST antibodies on the Cell DIVE multiplexed imaging solution, allowing researchers to design custom antibody biomarker panels.    Backed by a decade of research, the Cell DIVE iterative staining workflow enables the visualisation of over… Read More

#News

#Antibodies #Biologics #Data #Drug design #Exscientia

Exscientia extends capabilities beyond small molecules 

Throughout 2022, Exscientia has progressed AI-driven capabilities for virtual biologics design, such as human antibodies, and is now establishing an automated biologics laboratory in Oxford to internally generate and profile novel antibodies.   Context  Current approaches to optimise antibodies, even those that use machine learning, still… Read More

#News

Antibodies
#Antibodies #Antibody binding #Flow Cytometry #T cell activation #Whitepaper

Accelerate cancer and infectious disease workflows

Download this new whitepaper from Sartorius to understand the unique benefits of the high-throughput iQue Advanced Flow Cytometry Platform, combined with built-in, visual-based iQue Forecyt software, in the antibody discovery workflow. Learn analysis details of: Antibody binding Antibody internalisation and viability ADCP measurement in adherent cells ADCP measurement… Read More

#News

#Antibodies #Antibody binding #Flow Cytometry #T cell activation #Whitepaper

High throughput, multi-parametric analysis accelerates antibody discovery workflows

In this whitepaper, we present the unique benefits of the high-throughput iQue®Advanced Flow Cytometry Platform, combined with built-in, visual-based iQue Forecyt®software, in the antibody discovery workflow. Learn analysis details of: Antibody Binding Antibody Internalisation and Viability ADCP Measurement in Adherent Cells ADCP Measurement in Suspension Cells Quantification of NK Cell-Mediated… Read More

#Intelligence #Resources

HIV cell and antibodies
#Antibodies #Antivirals #HIV

Trial results support potential new therapeutic approach to HIV 

Positive study findings for N6LS, an investigational, broadly neutralising antibody (bNAb), could indicate a potential new approach for the treatment of HIV.  ViiV Healthcare, a specialist HIV company owned by GSK, Pfizer and Shionogi, presented positive findings from its Phase IIa proof-of-concept study of N6LS at the… Read More

#News

Flow cytometry
#Antibodies #Diagnostics #Drug discovery #Flow Cytometry

Leveraging flow cytometry in drug discovery 

Listen to this article on the DDW podcast: Dr Miguel A Tam, and Dr Kenta Yamamoto, BioLegend, examine the evolution, trends and best practices for smooth and efficient workflows for flow cytometry.  Flow cytometry is a well-established analytical technique that has been supporting reliable diagnostics and… Read More

#News

Vials for medical research
#Antibodies #Biomedical research #Drug development #Drug discovery #In vitro

New anti-evolocumab antibodies could aid drug development

Bio-Rad Laboratories has introduced a range of type 1 antibodies that inhibit the binding of evolocumab (Repatha) to its target, human proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that has been shown to play a key role in the regulation of cholesterol levels.  These sequence-defined, recombinant antibodies are… Read More

#News

SARS-CoV-2 virus particles
#Antibodies #Biomarkers #Clinical trials #Coronavirus #Covid-19 #Drug development #SARS-CoV-2

SARS-CoV-2 antigen levels could predict patient outcomes

The amount of SARS-CoV-2 antibodies in the blood of patients hospitalised with Covid-19 could be used to predict illness severity and other clinical outcomes.  A new study, published in the Annals of Internal Medicine, shows that higher levels of viral antigen in the blood, which… Read More

#Covid-19 #News

#Antibodies #Flow Cytometry #Screening

Faster, better, and more of it: What’s next for flow cytometry-based screening?

This paid-for advertorial by Bio-Rad appeared in the DDW ebook - Innovating in the lab: an essential guide to drug discovery technology. In the following article Richard J Cuthbert, PhD, Global Commercialisation Product Manager, Flow and Antibodies, Bio-Rad Laboratories examines the rise of flow cytometry as a screening tool. In recent years, the use… Read More

#Exclusive Content #Trends & Analysis

#Antibodies #Drug discovery #Drug screening

Carterra joins TetraScience Network to boost antibody services  

Life sciences company Carterra has joined data cloud company TetraScience’s network of partners to help generate insights into the potential of antibodies as drug candidates.  The Tetra Partner Network (TPN) is an ecosystem of partners which connects R&D data for pharmaceutical and biopharmaceutical customers.   Carterra… Read More

#News

#Antibodies #Target identification #The University of Manchester

University of Manchester expands antibody characterisation research   

The University of Manchester has added an instrument by Carterra to its Biomolecular Analysis Core Facility (BACF) within the Faculty of Biology, Medicine and Health (FBMH). The University has added Carterra’s LSA instrument to help assist with the development and characterisation of antibodies.   Created in 2005, the… Read More

#News

#Antibodies #Bi- and trispecifics #Fc-Fusion proteins #Humanisation

Understand the critical design parameters for engineering antibody formats

This whitepaper includes an introduction to antibodies and the process of antibody engineering based on Absolute Antibody’s years of experience developing recombinant versions of antibodies for a range of clients. This whitepaper will be valuable to: Therapeutic antibody developers Researchers designing antibodies for diagnostics Researchers looking to refine assays,… Read More

#News

Laboratory research
#Antibodies #Antibody Fragments #Bispecific Antibodies #Fc-Fusion proteins

App note: recombinant antibody formats, expressions & applications

Advancements in antibody engineering technologies have greatly enhanced the generation of recombinant antibodies in various formats as therapeutic agents. There are already more than 100 antibody-based drugs approved by the FDA, and numerous antibodies are currently in their late-stage clinical studies. Compared to monoclonal antibodies produced using traditional hybridoma techniques,… Read More

#News

#Antibodies #Antibody reagents #Assays

Learn how to generate and validate critical antibody reagents

Antibodies are critical reagents applied in multiple biological areas, such as scientific research, therapeutics, and diagnosis. High-quality and reliable antibody reagents are the foundation of good assay performance. To learn more generating and validating critical antibody reagents join this free event hosted by DDW and supported by Sino Biological. It… Read More

#News